期刊
ADDICTION BIOLOGY
卷 16, 期 1, 页码 142-144出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1369-1600.2010.00274.x
关键词
CYP2B6; fatalities; metabolism; methadone; OPRM1; pharmacogenomics
资金
- University scholarship for PhD research
The largest proportion of methadone-associated deaths occurs during the drug induction phase. We analysed methadone-related fatalities for gene variations linked with methadone action. A significant association between high methadone concentrations and the CYP2B6*6 allele characteristic of the slow metabolizer phenotype was identified. We suggest that the risk of methadone fatality may be predetermined in part by the CYP2B6*6 allele. A significant correlation was also observed between post-mortem benzodiazepine concentrations and the OPRM1 A118G allele GA in methadone-related fatalities. Screening for these susceptibility variations prior to methadone prescription could assist in reducing the potential for serious adverse effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据